Literature DB >> 2497706

Susceptibility and bactericidal activity studies of four beta-lactamase-producing enterococci.

J E Patterson1, M J Zervos.   

Abstract

beta-Lactamase-producing (Bla+) enterococci are rare but have been reported from several areas. We report another Bla+ enterococcus with high-level gentamicin resistance. Susceptibility and bactericidal activity studies of four Bla+ enterococci against potential alternative antibiotics, including ampicillin-sulbactam, daptomycin, teicoplanin, and vancomycin, are presented.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2497706      PMCID： PMC171469          DOI： 10.1128/AAC.33.2.251

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  Activity of LY146032 against Enterococci with and without high-level aminoglycoside resistance, including two penicillinase-producing strains.

Authors:  A R Wanger; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

2.  Comparison of two beta-lactamase-producing strains of Streptococcus faecalis.

Authors:  B E Murray; D A Church; A Wanger; K Zscheck; M E Levison; M J Ingerman; E Abrutyn; B Mederski-Samoraj
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

3.  Prevalence of high-level resistance to aminoglycosides in clinical isolates of enterococci.

Authors:  R C Moellering; C Wennersten; T Medrek; A N Weinberg
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

4.  Serious infection due to beta-lactamase-producing Streptococcus faecalis with high-level resistance to gentamicin.

Authors:  J E Patterson; S M Colodny; M J Zervos
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

5.  Antimicrobial therapy of experimental enterococcal endocarditis.

Authors:  E W Hook; R B Roberts; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

6.  beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis.

Authors:  M Ingerman; P G Pitsakis; A Rosenberg; M T Hessen; E Abrutyn; B E Murray; M E Levison
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

7.  Method of reliable determination of minimal lethal antibiotic concentrations.

Authors:  R D Pearson; R T Steigbigel; H T Davis; S W Chapman
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

8.  Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis.

Authors:  B E Murray; B Mederski-Samaroj
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

9.  In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis.

Authors:  M Fernandez-Guerrero; M S Rouse; N K Henry; J E Geraci; W R Wilson
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

10.  Synergism of vancomycin-gentamicin and vancomycin-streptomycin against enterococci.

Authors:  C Watanakunakorn; C Bakie
Journal:  Antimicrob Agents Chemother       Date:  1973-08       Impact factor: 5.191
View more
  17 in total

Review 1.  Beta-lactamase-producing enterococci.

Authors:  B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

2.  Molecular epidemiology of beta-lactamase-producing enterococci.

Authors:  J E Patterson; A Wanger; K K Zscheck; M J Zervos; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

3.  Ampicillin-resistant enterococci.

Authors:  E Cercenado; M E García-Leoni; P Rodeño; M Rodríguez-Créixems
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

4.  Intrahospital spread of a single gentamicin-resistant, beta-lactamase-producing strain of Enterococcus faecalis in Argentina.

Authors:  B E Murray; H A Lopardo; E A Rubeglio; M Frosolono; K V Singh
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

5.  Epidemiology of an endemic strain of beta-lactamase-producing Enterococcus faecalis.

Authors:  J E Patterson; K V Singh; B E Murray
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

6.  Activities and time-kill studies of selected penicillins, beta-lactamase inhibitor combinations, and glycopeptides against Enterococcus faecalis.

Authors:  D B Hoellman; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

Review 7.  Pathogenicity of the enterococcus in surgical infections.

Authors:  P S Barie; N V Christou; E P Dellinger; W R Rout; H H Stone; J P Waymack
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

8.  Antimicrobial susceptibility and molecular epidemiology of beta-lactamase-producing, aminoglycoside-resistant isolates of Enterococcus faecalis.

Authors:  S M Markowitz; V D Wells; D S Williams; C G Stuart; P E Coudron; E S Wong
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

9.  DNA hybridization and contour-clamped homogeneous electric field electrophoresis for identification of enterococci to the species level.

Authors:  S Donabedian; J W Chow; D M Shlaes; M Green; M J Zervos
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

10.  Lack of homology of enterococci which have high-level resistance to trimethoprim with the dfrA gene of Staphylococcus aureus.

Authors:  M Frosolono; S L Hodel-Christian; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.